Mani, Inc. (TYO:7730)

Japan flag Japan · Delayed Price · Currency is JPY
1,692.00
+23.00 (1.38%)
May 8, 2026, 3:30 PM JST
Market Cap166.67B +43.9%
Revenue (ttm)31.26B +6.3%
Net Income5.60B -7.2%
EPS56.86 -7.2%
Shares Out98.50M
PE Ratio29.76
Forward PE21.99
Dividend41.00 (2.46%)
Ex-Dividend DateAug 28, 2026
Volume334,100
Average Volume553,150
Open1,688.00
Previous Close1,669.00
Day's Range1,680.00 - 1,733.00
52-Week Range1,168.00 - 1,955.00
Beta0.36
RSI51.45
Earnings DateApr 14, 2026

About Mani, Inc.

Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Products. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, and stainless wire needles; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needle... [Read more]

Sector Healthcare
Founded 1956
Employees 4,140
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7730
Full Company Profile

Financial Performance

In fiscal year 2025, Mani, Inc.'s revenue was 29.97 billion, an increase of 5.10% compared to the previous year's 28.51 billion. Earnings were 4.64 billion, a decrease of -26.14%.

Financial Statements

News

Q1 2026 MANI Inc Earnings Presentation Transcript

Q1 2026 MANI Inc Earnings Presentation Transcript

3 months ago - GuruFocus

Full Year 2025 MANI Inc Earnings Presentation Transcript

Full Year 2025 MANI Inc Earnings Presentation Transcript

3 months ago - GuruFocus

Q2 2025 MANI Inc Earnings Presentation Transcript

Q2 2025 MANI Inc Earnings Presentation Transcript

6 months ago - GuruFocus

Mani, Inc. Earnings Call Transcript: Q2 2025

Voluntary recall in China led to a JPY 800 million sales hit, but strong Surgical and Eyeless Needle Segments offset the impact, keeping Q2 FY2025 results in line with forecasts. Full-year guidance and dividends remain unchanged.

1 year ago - Transcripts

Mani, Inc. Earnings Call Transcript: Q1 2025

Management is accelerating growth plans, targeting JPY 50B in sales and 16% ROE by FY2029, with new products and global expansion as key drivers. Strategic investments, operational improvements, and proactive risk management underpin the outlook.

1 year ago - Transcripts